How the Trump administration has ignored some of the key lessons in how to pass health reform through Congress, NBC News reports.
Here are some of the key stories CNBC is following this hour.
"The idea that perhaps Medicaid programs, which are struggling to pay for those programs, that they could have potentially received rebates is disturbing to me." Mylan has been criticized for listing EpiPen with Medicaid as a generic product even though it listed it with the Food and Drug Administration as a branded product. The classification led to Mylan's...
WASHINGTON, Jan 23- Endo International Plc said on Monday it has reached a proposed settlement with U.S. antitrust regulators under which it will not pay rivals to delay the introduction of generic competitors to its medications. The Federal Trade Commission had alleged Endo paid Impax Laboratories Inc to delay the introduction of a generic version of its...
President-elect Donald Trump officially announced Sonny Perdue as his choice for secretary of agriculture on Thursday, selecting a former Georgia governor over candidates from the Midwest states that dominate U.S. agricultural exports. He was elected to two terms as governor of Georgia, a leading producer of cotton and peanuts, serving from 2003 to 2011.
President-elect Donald Trump officially announced Sonny Perdue as his choice for secretary of agriculture on Thursday, selecting a former Georgia governor over candidates from the Midwest states that dominate U.S. agricultural exports. He served two terms as Georgia governor from 2003 to 2011. Georgia accounted for just 2 percent of total U.S. agriculture...
Republicans won key Senate races as Democrats have only been able to flip two seats in Illinois and New Hampshire.
There needs to be more transparency in drug pricing, and Mylan still has a lot of questions to answer, Sen. Charles Grassley said Thursday.
Two senior lawmakers on the U.S. Senate's Judiciary Committee pushed for information regarding sharp price increases for EpiPens.
Led by Civil Rights veteran Rep. John Lewis, House Democrats are trying to force a vote on gun control, NBC News reports.
U.S. President Barack Obama will press Senate Republican leaders on Tuesday to fill the vacancy on the Supreme Court.
An audit said there were ineffective internal controls to ensure that $2.8 billion given insurers was accurately disbursed.
The Obama administration may need to make still more changes to protect consumer privacy on the government's health insurance website.
Two U.S. congressmen have opened separate inquiries into whether a Treasury Department bureau may have flouted federal hiring rules.
In light of the federal indictments against SAC, Sen. Chuck Grassley says that he would want to see founder Steven A. Cohen testify before Congress.
Sen. Chuck Grassley says IRS officials targeted political candidates for audits, and a major player in the Mexican drug trade has been caught. CNBC's Josh Lipton has tonight's headlines; and Retired General and former drug czar Barry McCaffrey, weighs in.
CNBC's Eamon Javers reports the IRS is now poised to pay $70 million in bonuses to some employees. Sen. Charles Grassley (R-IA) says the report is accurate. "The priorities at the agency are certainly not the taxpayers," he says.
Oct 25- Medical device maker Medtronic Inc edited health journal articles and paid doctors millions of dollars for company-sponsored studies of its Infuse bone-grafting product used in spinal surgery, according to a U.S. Senate report published on Thursday.
Ex-Inspector General David Kotz was friends with people close to his investigations related to two high-profile Ponzi schemes, and he had a flirtatious relationship with an SEC employee who was involved in another project involving Kotz's office, according to the report.
By Sarah N. Lynch and Alexandra Alper. WASHINGTON, Oct 2- Two Senate Republicans on Tuesday slammed Treasury Secretary Timothy Geithner for failing to wean U.S. firms off a key British benchmark interest rate that he knew was being rigged, resulting, the lawmakers said, in costly litigation that hurts American taxpayers.